These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23522835)
1. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells. Le TV; Suh JH; Kim N; Park HJ Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835 [TBL] [Abstract][Full Text] [Related]
2. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092 [TBL] [Abstract][Full Text] [Related]
3. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor. Wang B; Qian H; Yiu SM; Sun J; Zhu G Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors. Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803 [TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA. Guggenheim ER; Ondrus AE; Movassaghi M; Lippard SJ Bioorg Med Chem; 2008 Dec; 16(23):10121-8. PubMed ID: 18977144 [TBL] [Abstract][Full Text] [Related]
6. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors. Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115 [TBL] [Abstract][Full Text] [Related]
7. The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. Zheng YD; Xu XQ; Peng F; Yu JZ; Wu H Oncol Rep; 2011 May; 25(5):1399-405. PubMed ID: 21399878 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity. Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453 [TBL] [Abstract][Full Text] [Related]
9. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. Mendes F; Groessl M; Nazarov AA; Tsybin YO; Sava G; Santos I; Dyson PJ; Casini A J Med Chem; 2011 Apr; 54(7):2196-206. PubMed ID: 21370912 [TBL] [Abstract][Full Text] [Related]
11. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Putt KS; Hergenrother PJ Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338 [TBL] [Abstract][Full Text] [Related]
12. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes. Tentori L; Portarena I; Vernole P; Gold B; Graziani G Cancer Chemother Pharmacol; 2002 Mar; 49(3):217-24. PubMed ID: 11935214 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly(ADP-ribose) polymerase in cancer. Plummer ER Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors. Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. Tikhe JG; Webber SE; Hostomsky Z; Maegley KA; Ekkers A; Li J; Yu XH; Almassy RJ; Kumpf RA; Boritzki TJ; Zhang C; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR J Med Chem; 2004 Oct; 47(22):5467-81. PubMed ID: 15481984 [TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Jagtap P; Szabó C Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271 [TBL] [Abstract][Full Text] [Related]